NYSE · Medical - Devices

GKOS (GKOS) Stock

$166.72 -1.07% NYSE: GKOS Healthcare

Valuation

MetricValue
Price$166.72
Market Cap$9.83B
P/E Ratio-42.65
P/B Ratio12.53
P/S Ratio14.90
EPS (TTM)$-3.28
52-Week High$166.72
52-Week Low$73.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-28.66%
ROA-21.05%
ROCE-13.26%
Gross Margin-17.16%
Operating Margin-17.16%
Net Margin-34.34%
Debt/Equity0.15
Current Ratio4.70

Annual Financials (USD)

Metric20212022202320242025
Revenue$294.0M$283.0M$315.0M$383.0M$507.0M
Operating Profit$-33.0M$-82.0M$-129.0M$-122.0M$-87.0M
Net Profit$-50.0M$-99.0M$-135.0M$-146.0M$-188.0M
EPS$-1.07$-2.09$-2.78$-2.77$-3.28
Op Margin-11.2%-29.1%-40.9%-31.9%-17.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.1B$1.1B$940.0M$975.0M$893.0M
Total Liabilities$542.0M$544.0M$479.0M$208.0M$237.0M
Cash$101.0M$120.0M$93.0M$170.0M$91.0M
Borrowings$383.0M$383.0M$384.0M$106.0M$140.0M

Latest News

Truist Adjusts Price Target on Glaukos to $180 From $160, Maintains Buy Rating MT Newswires · Jul 16, 2026 GKOS: Raising target price to $160.00 Argus Research · Jul 15, 2026 Glaukos CFO Alex Thurman Sells $1.6 Million in Stock. What Should Investors Do Now? Motley Fool · Jul 14, 2026 Glaukos Insider Sold Shares Worth $1,550,000, According to a Recent SEC Filing MT Newswires · Jul 14, 2026 Glaukos Insider Sold Shares Worth $1,500,000, According to a Recent SEC Filing MT Newswires · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$25.0M$-33.0M$-58.0M$-61.0M$-46.0M
Investing Cash Flow$-106.0M$15.0M$-6.0M$42.0M$-85.0M
Financing Cash Flow$9.0M$-2.0M$-3.0M$-7.0M$12.0M
Net Cash Flow$4.0M$19.0M$-26.0M$76.0M$-111.0M
Free Cash Flow$-23.0M$-63.0M$-78.0M$-68.0M$-54.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-0.22%
Quick Ratio4.73
Interest Coverage-17.40
Return 1Y58.27%
Return 3Y104.50%
Return 5Y206.18%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACLXArcellx, Inc. $115.07 +0.02% -28.27 $6.73B 0.00%
ALKS $50.71 -3.84% 25.87 $8.45B 0.00%
ARWR $86.01 +1.61% -7397.00 $12.12B 0.00%
BLCO $16.76 +0.48% 13.97 $5.99B 0.00%
BRKR $62.91 +4.76% 23.24 $9.58B 0.35%

About GKOS

GKOS is led by CEO Thomas William Burns, employs 1,094 people, headquartered in Aliso Viejo, US, publicly traded since 2015.

GKOS stock trades at $166.72 with a market capitalization of $9.83B. The stock is valued at a price-to-earnings (P/E) ratio of -42.65, price-to-book of 12.53, price-to-sales of 14.90. Over the past 52 weeks the stock has ranged between $73.16 and $166.72, and currently trades at its 52-week high.

On profitability, GKOS generates a return on equity (ROE) of -28.66%, return on capital employed of -13.26%, an operating margin of -17.16%, a net profit margin of -34.34%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides